This Article Abstract Full Text (PDF) All Versions of this Article: 36/2/342    most recent 01.STR.0000152952.42730.92v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Didion, S. P. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Didion, S. P. Articles by Faraci, F. M. Related Collections Animal models of human disease Type 2 diabetes Endothelium/vascular type/nitric oxide

(Stroke. 2005;36:342.)
© 2005 American Heart Association, Inc.

Original Contributions

Impaired Endothelium-Dependent Responses and Enhanced Influence of Rho-Kinase in Cerebral Arterioles in Type II Diabetes

From the Departments of Internal Medicine (S.P.D., C.M.L., F.M.F.), Pathology (G.L.B.), and Pharmacology (F.M.F.), Cardiovascular Center, University of Iowa Carver College of Medicine Iowa City.

Correspondence to Dr Sean P. Didion, Department of Internal Medicine, University of Iowa Carver College of Medicine Iowa City, IA 52242. E-mail sean-didion{at}uiowa.edu

	Abstract

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Background and Purpose— Although the incidence of type II diabetes is increasing, very little is known regarding vascular responses in the cerebral circulation in this disease. The goals of this study were to examine the role of superoxide in impaired endothelium-dependent responses and to examine the influence of Rho-kinase on vascular tone in the cerebral microcirculation in type II diabetes.

Methods— Diameter of cerebral arterioles (29±1 µm; mean±SE) was measured in vivo using a cranial window in anesthetized db/db and control mice.

Results— Dilatation of cerebral arterioles in response to acetylcholine (ACh; 1 and 10 µmol/L), but not to nitroprusside, was markedly reduced in db/db mice (eg, 10 µmol/L ACh produced 29±1% and 9±1% in control and db/db mice, respectively). Superoxide levels were increased (P<0.05) in cerebral arterioles from db/db mice (n=6) compared with controls (n=6). Vasodilatation to ACh in db/db mice was restored to normal by polyethylene glycol-superoxide dismutase (100 U/mL). Y-27632 (1 to 100 µmol/L; a Rho-kinase inhibitor) produced modest vasodilatation in control mice but much greater responses in db/db mice. N^G-nitro-L-arginine (100 µmol/L; an inhibitor of NO synthase) significantly enhanced Y-27632–induced dilatation in control mice to similar levels as observed in db/db mice.

Conclusions— These findings provide the first evidence for superoxide-mediated impairment of endothelium-dependent responses of cerebral vessels in any model of type II diabetes. In addition, the influence of Rho-kinase on resting tone appears to be selectively enhanced in the cerebral microcirculation in this genetic model of type II diabetes.

Key Words: cerebral circulation • diabetes mellitus, type II • reactive oxygen species

	Introduction

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Type II diabetes is a major risk factor for carotid artery disease and stroke as well as Alzheimer disease.^1–4 For example, patients with type II diabetes are at a 2- to 4-fold higher risk for stroke than patients without diabetes.¹ Although type II diabetes accounts for 90% of all cases of diabetes in humans,¹ there is very little data regarding vascular function in type II diabetes in the cerebral circulation and even less known about mechanisms of vascular dysfunction in this disease.

Endothelium-dependent relaxation is impaired in peripheral blood vessels in type II diabetes in animal models and in patients.^5–11 In contrast, very little is known regarding endothelium-dependent responses of cerebral vessels during type II diabetes.^12,13 Because the incidence of type II diabetes is increasing and because cerebral vascular responses in type II diabetes have not been examined in great detail, the first goal of this study was to test whether dilatation of cerebral arterioles in response to endothelium-dependent and -independent agonists is altered in type II diabetes. The study of endothelial function seems particularly appropriate, because endothelial dysfunction has emerged as an independent predictor of clinical events.¹⁴

Several mechanisms have been proposed to account for impairment of endothelium-dependent relaxation in peripheral blood vessels in type II diabetes, including enhanced production of reactive oxygen species, particularly superoxide, and reduced bioactivity of endothelium-derived NO.^5,6,8,9 Thus, a second goal of this study was to examine the importance of superoxide in impairment of endothelium-dependent responses of cerebral arterioles in type II diabetes.

Recently, alterations in Rho-kinase activity have been implicated in cerebral blood vessels in hypertension.¹⁵ Activity of Rho-kinase affects calcium sensitivity and may affect resting tone of cerebral blood vessels. In addition, activity of Rho-kinase may be inhibited by NO.^16–18 Thus, a third goal of this study was to examine whether the influence of Rho-kinase on vascular tone was altered in type II diabetes. We hypothesized that the influence of Rho-kinase would be increased in type II diabetes and that a reduction in NO bioavailability would result in enhanced Rho-kinase activity. To accomplish these goals, we examined responses of cerebral arterioles in db/db mice, a genetic model of type II diabetes characterized by hyperinsulinemia, insulin-resistance, hyperglycemia, and obesity.¹⁹

	Methods

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Experimental Preparation
Male db/db mice (n=32) and their nondiabetic controls (C57BlKs; n=42) were obtained from The Jackson Laboratory (Bar Harbor, Me). Animals had access to food and water ad libitum and were housed in the Animal Care Unit. All experimental protocols were reviewed and approved by The University of Iowa Animal Care and Use Committee before the start of these studies.

Animals were anesthetized with pentobarbital sodium (75 to 90 mg/kg IP), supplemented at 10 to 20 mg/kg per hour. The trachea was cannulated, and the animals were ventilated mechanically with air and supplemental oxygen. A femoral artery was cannulated for measurement of systemic pressure, to sample arterial blood including for determination of glucose levels. Arterial pressure under anesthesia was similar in the 2 groups and averaged 70 mm Hg. Arterial blood gases were measured and were found to be similar in the 2 groups(PCO₂, 36±1 mm Hg; PO₂, 143±7 mm Hg; and pH, 7.32±0.01).

A cranial window was made over the left parietal cortex, and a segment of a pial arteriole was exposed as described previously.²⁰ All drugs were applied topically over the cerebral vessels. Application of vehicle did not affect vessel diameter.

Experimental Protocols
Five groups of animals were studied. In all groups, diameter of 1 arteriole per animal was measured under control conditions and during application of drugs. In the first group, changes in arteriolar diameter were measured in response to the endothelium-dependent dilator acetylcholine (ACh; 1 and 10 µmol/L) and to the endothelium-independent dilators nitroprusside (0.1 and 1 µmol/L) and papaverine (10 and 100 µmol/L). All vasodilators were applied cumulatively, and the sequence of each was tested in a random manner.

In the second group, we sought to determine whether superoxide contributes to the alterations in vascular responses in type II diabetes. Changes in arteriolar diameter were measured in response to ACh and nitroprusside. After the first application of agonists, a 30-minute recovery period was allowed, and application of ACh and nitroprusside was repeated in the presence of polyethylene glycol-superoxide dismutase (PEG-SOD; 100 U/mL) or vehicle (control). We have shown previously that this concentration of PEG-SOD is within that which is efficacious in reducing superoxide levels in blood vessels.^20–22 The cranial window was treated with PEG-SOD or vehicle for 30 minutes before and during the second application of agonists.

In the third group, we sought to determine whether the influence of Rho-kinase on arteriolar tone is altered in type II diabetes. To accomplish this, we examined effects of Y-27632 (a Rho-kinase inhibitor;²³ 1 to 100 µmol/L) on baseline tone in control and db/db mice.

In the fourth group, we sought to determine whether the influence of protein kinase C (PKC) on arteriolar tone and the relative contribution is altered during diabetes. We examined effect of calphostin C (a selective PKC inhibitor;^15,24 0.01 to 1 µmol/L) on baseline diameter in control and db/db mice.

In the fifth group, we determined whether inhibition of NO production results in an enhanced influence of Rho-kinase on vascular tone in control mice and thus provides a potential mechanistic link between impaired NO-mediated responses and enhanced Rho-kinase activity in db/db mice. We examined the effect of 100 µmol/L N^G-nitro-L-arginine (L-NNA; a NO synthase inhibitor) or vehicle for 30 minutes before and during application of ACh and Y-27632.

Detection of Superoxide
Superoxide levels were evaluated in cerebral arterioles using hydroethidine-based confocal microscopy as described previously.^20,22 Briefly, sections of cerebral arterioles from control (n=6) and db/db (n=6) mice were frozen in optimal cutting temperature compound, sectioned (30 µm) onto glass slides, and incubated with hydroethidine (2 µmol/L) for 30 minutes. Positive staining (red fluorescence) for superoxide was determined with a Noran Odyssey laser scanning confocal microscope equipped with a krypton/argon laser. Fluorescence was detected with a 585-nm long-pass filter. Laser settings were identical for acquisition of images, and vessels from control and db/db mice were processed and imaged in parallel. Relative increases in fluorescence were determined in a blinded manner using NIH Image software (v 1.62) and was normalized to the cross-sectional area of the vessel wall.

Drugs
ACh, calphostin C, L-NNA, papaverine, PEG-SOD, and sodium nitroprusside were obtained from Sigma Chemical Co, and all were dissolved in saline. Y-27632 was obtained from CalBioChem and dissolved in milli-Q water. Hydroethidine was obtained from Molecular Probes and was dissolved in dimethyl sulfoxide.

Statistical Analysis
Vascular responses are presented as a percent change in diameter compared with baseline. For comparison of vessel diameter under control conditions and during application of agonists as well as for comparison of superoxide levels, statistical analysis was performed with the use of paired or unpaired t tests as appropriate. All values are expressed as mean±SE. P<0.05 was considered significant.

	Results

Top Abstract Introduction Methods Results Discussion Conclusions References

 
Baseline Parameters
Body weight (43±1 versus 29±1 g) and blood glucose (570±39 versus 108±8, mg/dL) were greater (P<0.05) in db/db mice than in control mice, respectively. Mice used were of similar age (5±0.3 months). Baseline arteriolar diameter was slightly less (P<0.05) in db/db mice (28±1 µm, n=26 and 31±1 µm, n=36 in db/db and control mice, respectively).

Cerebral Dilator Responses in db/db Mice
ACh produced dilatation of cerebral arterioles in control mice and this response was markedly impaired in db/db mice (Figure 1). This finding indicates that endothelium-dependent dilatation of cerebral arterioles in response to ACh is impaired in db/db mice.

View larger version (14K): [in this window] [in a new window]   Figure 1. Vasodilator responses to ACh (left, n=26) and nitroprusside (right, n=19 to 20) in control and db/db mice. Vasodilatation in response to acetylcholine (ACh), but not nitroprusside, was impaired in db/db mice compared with controls. *P<0.05 versus control mice.

Nitroprusside (Figure 1) and papaverine (10 µmol/L: 33±9 and 29±5%; 100 µmol/L: 61±5 and 54±5% in control and db/db mice, respectively) produced dilatation of cerebral arterioles that was similar in both groups. Thus, impaired responses to ACh in db/db mice were selective.

Effect of PEG-SOD on Endothelium-Dependent Responses
In both control and db/db mice, ACh produced vasodilatation that was reproducible. For example, in control mice, ACh dilated cerebral arterioles by 16±1% and 35±5% before suffusion of vehicle and 15±3% and 36±6%, respectively, after suffusion of vehicle. Vasodilator responses to ACh were similar (P>0.05) in the absence and presence of PEG-SOD in control mice (Figure 2, left). In contrast, dilatation of cerebral arterioles in response to ACh was restored to normal levels by PEG-SOD in db/db mice (Figure 2, right).

View larger version (15K): [in this window] [in a new window]   Figure 2. Vasodilator responses to ACh in control (left, n=3) and db/db mice (right, n=5) before application of PEG-SOD (control; ) and after application of PEG-SOD (100 U/mL; ). Vasodilatation in response to ACh was significantly enhanced in the presence of PEG-SOD in db/db mice. *P<0.05 versus control response.

Consistent with results obtained with PEG-SOD, superoxide levels, as measured using hydroethidine, were increased (P<0.05) in cerebral arterioles from db/db mice as compared with that from control mice (Figure 3).

View larger version (18K): [in this window] [in a new window]   Figure 3. Representative confocal fluorescent sections of cerebral arterioles from control (top left, n=6) and db/db (top right, n=6) mice incubated with hydroethidine for detection of superoxide. Fluorescent intensity (relative units) expressed as a percentage of the vessel wall (bottom) was increased in db/db mice as compared with controls. *P<0.05. Scale bar=20 µm.

Effect of Inhibition of Rho-Kinase and PKC on Vascular Tone
Application of Y-27632 produced increases in diameter of cerebral arterioles in control mice (Figure 4). This response was augmented in db/db mice (Figure 4), suggesting that the influence of Rho-kinase on resting cerebral microvascular tone is increased in type II diabetes.

View larger version (13K): [in this window] [in a new window]   Figure 4. Effect of cumulative application of the Rho-kinase inhibitor Y-27632 (left) on cerebral arteriolar diameter in control (n=7) and db/db (n=5) mice. Y-27632 produced modest dilatation in control mice, whereas Y-27632 produced dilatation that was nearly 2- to 3-fold greater in db/db mice. Effect of cumulative application of the PKC inhibitor calphostin C (right) on cerebral arteriolar diameter in control (n=5) and db/db (n=4) mice. Dilatation in response to calphostin C was significantly impaired in db/db mice. *P<0.05 versus control mice.

Application of calphostin C produced dilatation in cerebral arterioles in control mice (Figure 4) and this response was reduced in db/db mice. These findings suggest that the increased influence of Rho-kinase on basal tone is selectively increased in type II diabetes.

Effect of L-NNA on Responses to ACh and Y-27632
In time control experiments, ACh produced a reproducible response in the presence vehicle in control mice (data not shown). Vasodilatation to ACh was markedly inhibited by L-NNA (Figure 5).

View larger version (15K): [in this window] [in a new window]   Figure 5. Vascular response to ACh before (control) and after 30-minute suffusion of L-NNA in control mice (right). *P<0.05 versus control.

Y-27632 produced modest dilatation in cerebral arterioles of control mice (Figure 6). Vasodilatation to Y-27632 was markedly enhanced after L-NNA treatment (Figure 6). These findings suggest that inhibition of NO production is associated with an increased influence of Rho-kinase on resting tone.

View larger version (15K): [in this window] [in a new window]   Figure 6. Vascular responses to Y-27632 before (vehicle) and after 30-minute suffusion of L-NNA in control mice. *P<0.05 versus vehicle.

	Discussion

Top Abstract Introduction Methods Results Discussion Conclusions References

 
There are 3 major new findings of this study. First, dilatation of cerebral arterioles in response to the endothelium-dependent dilator ACh was markedly reduced in db/db mice as compared with controls. This effect appears to be selective for endothelium as vascular responses to the endothelium-independent dilators were similar in control and db/db mice. Second, application of PEG-SOD, a superoxide scavenger, normalized dilator responses to ACh in db/db mice but had no effect on dilator response to ACh in control mice. Consistent with these findings, we also found that superoxide levels in cerebral arterioles were increased in db/db mice as determined using hydroethidine. To our knowledge, this is the first evidence, implicating a role for superoxide in impaired endothelium-dependent responses of cerebral blood vessels in type II diabetes. Third, Y-27632 produced greater dilatation of cerebral arterioles in db/db mice compared with controls. This effect was mimicked in control mice after inhibition of nitric-oxide synthase with L-NNA, suggesting that reductions in NO bioavailability are associated with increases in Rho-kinase activity. In contrast, calphostin C produced dilatation of cerebral arterioles in control mice, which was significantly reduced in db/db mice. These findings suggest that the relative influence of Rho-kinase on basal tone is enhanced in type II diabetes.

Cerebral Vascular Responses in Type II Diabetes
Previous studies have demonstrated that endothelium-dependent responses of peripheral blood vessels are impaired in experimental models of type II diabetes. In terms of the cerebral circulation, most studies have focused on the effect of type I diabetes on vascular responses.^25–26 Only recently have studies begun to examine the effect of type II diabetes on the cerebral circulation.^12–13

We found that response to the endothelium-dependent dilator ACh was selectively impaired in db/db mice. While the present study was ongoing, it was reported that cerebral blood vessels in Zucker rats, a model of type II diabetes with hypertension, have impaired endothelium-dependent responses.^12,13 The studies of the Zucker rat did not define a mechanism(s) that accounted for the impairment. Thus, this study is the first, to our knowledge, to provide insight into mechanisms that account for vascular dysfunction in the cerebral circulation in type II diabetes.

Impaired Cerebral Vascular Responses in Type II Diabetes: Role of Superoxide
We and others have shown that superoxide can impair endothelium-dependent responses of cerebral blood vessels.^20,27–30 Thus, we examined the role of superoxide in impaired endothelium-dependent responses of cerebral arterioles and found that PEG-SOD restored responses to ACh in db/db mice to that observed in controls. In parallel with these results, we found that superoxide levels were increased in the cerebral arterioles as detected using hydroethidine-based confocal microscopy. Our results are consistent with previous findings, which suggested that superoxide contributes to impaired endothelium-dependent responses in peripheral blood vessels in type II diabetes,^5,6,8,9,10 but are the first to implicate superoxide as a mediator of endothelial dysfunction in the cerebral circulation in type II diabetes. A recent study suggests that superoxide may also produce impaired endothelial function in cerebral arteries in a model of insulin resistance.³¹

Influence of PKC and Rho-Kinase on Cerebral Vascular Tone
Vascular tone is determined by many mechanisms, including the activity of both constrictor and dilator pathways. Rho-kinase and PKC have been suggested to play an important role in regulation of vascular tone.^15,16,23 Although relatively little is known, activity of Rho-kinase and PKC may influence cerebral vascular tone under normal conditions.¹⁵ This influence may change during disease states.

Recently, it has been suggested that NO may influence vascular contractility through inhibition of Rho-kinase.^16,17 Increases in superoxide could reduce the inhibition of Rho-kinase by NO, thereby increasing calcium-sensitivity.^16–18 Thus, in this study, we set out to determine the relative influence of Rho-kinase and PKC on cerebral vascular tone under normal conditions and in type II diabetes. We used Y-27632 to examine the influence of Rho-kinase on vascular tone in control and db/db mice. Y-27632 is a competitive inhibitor of the ATP-binding site on Rho-kinase and has been shown to be highly selective for Rho-kinase.²³ We found that Y-27632 produced dilatation of cerebral arterioles in control mice, suggesting that activity of Rho-kinase influences vascular tone under basal conditions. Importantly, Y-27632 produced much greater dilatation of cerebral arterioles in db/db mice.

Inhibition of NO production with L-NNA produced increases in Y-27632–induced vasodilatation in control mice. This change was analogous to the increased Y-27632–induced responses observed in db/db mice, a model with impaired NO-mediated signaling in cerebral arterioles. These results are consistent with the emerging concept that NO may inhibit Rho-kinase activity.^16–18 These findings also provide a potential mechanistic link between studies related to impairment of vascular responses by superoxide and increases in Rho-kinase activity in db/db mice.

In parallel experiments, we examined the influence of PKC, which has also been implicated in calcium-sensitization of smooth muscle to vasoconstrictor stimuli.¹⁵ We used calphostin C, which has been shown previously to be an efficacious and selective inhibitor of PKC.^24,32 Calphostin C produced vasodilatation under basal conditions, suggesting that activity of PKC is normally functionally important. In contrast, the influence of PKC appears to be reduced in type II diabetes because calphostin C produced less vasodilatation in db/db mice. We speculate that the decreased influence of PKC may be a compensatory response to offset the increased influence of Rho-kinase to maintain resting vessel diameter at near normal levels in type II diabetes.

	Conclusions

Top Abstract Introduction Methods Results Discussion Conclusions References

 
These findings provide the first evidence for superoxide-mediated impairment of endothelial function in cerebral blood vessels in a genetic model of type II diabetes. In addition, activity of Rho-kinase appears to be selectively enhanced in this model. We speculate that such functional changes in type II diabetes may predispose cerebral vessels to enhanced vasoconstriction and may contribute to increased risk for stroke.

	Acknowledgments

 
This work was supported by National Institutes of Health grants NS-24621, HL-38901, HL-62984 (to F.M.F) and HL-22149 (to G.L.B). S.P.D. was supported by DK-25295 and a National Scientist Development Grant from the American Heart Association (0230327N). We thank Tom Gerhold and Shams Ghoneim for excellent technical assistance and the Department of Pathology Research Histology Laboratory.

Received October 18, 2004; accepted November 15, 2004.

	References

Top Abstract Introduction Methods Results Discussion Conclusions References

 
1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet; United States; November 2003.

2. Niskanen L, Rauramma R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke. 1996; 27: 1986–1992.[Abstract/Free Full Text]

3. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E. O’Brien PC, Palumbo PJ. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol. 1997; 145: 301–308.[Abstract/Free Full Text]

4. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia. 1995; 38: 1061–1068.[Medline] [Order article via Infotrieve]

5. Frisbee JC, Maier KG, Stepp DW. Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats. Am J Physiol Heart Circ Physiol. 2002; 283: H2160–H2168.[Abstract/Free Full Text]

6. Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2003; 285: H1404–H1410.[Abstract/Free Full Text]

7. Hogikyan RV, Galecki AT, Pitt B, Halter JB, Greene DA, Supiano MA. Specific impairment of endothelium-dependent vasodilatation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab. 1998; 83: 1946–1952.[Abstract/Free Full Text]

8. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilatation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996; 97: 22–28.[Medline] [Order article via Infotrieve]

9. Pannirselvam M, Verma S, Anderson TJ, Triggle CR. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db–/–) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol. 2002; 136: 255–263.[CrossRef][Medline] [Order article via Infotrieve]

10. Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically-diabetic BB rat. Life Sci. 1996; 58: 147–152.

11. Piercy V, Taylor SG. A comparison of spasmogenic and relaxant responses in aortae from C57/BL/KsJ diabetic mice with those from their non-diabetic littermates. Pharmacology. 1998; 56: 267–275.[CrossRef][Medline] [Order article via Infotrieve]

12. Schwaninger RM, Sun H. Mayhan WG. Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci. 2003; 73: 3415–3425.[CrossRef][Medline] [Order article via Infotrieve]

13. Karagiannis J, Reid JJ, Darby I, Roche P, Rand MJ, Li CG. Impaired nitric oxide function in the basilar artery of the obese Zucker rat. J Cardiovasc Pharmacol. 2003; 42: 497–505.[CrossRef][Medline] [Order article via Infotrieve]

14. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23: 168–175.[Abstract/Free Full Text]

15. Chrissobolis S, Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo is enhanced during chronic hypertension. Circ Res. 2001; 88: 774–779.[Abstract/Free Full Text]

16. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G, Cyclic GM. P-dependent protein kinase signaling pathway inhibits RhoA-induced Ca++ sensitization of contraction in vascular smooth muscle. J Biol Chem. 2000; 275: 21722–21729.[Abstract/Free Full Text]

17. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension. 2002; 39 (part 2): 438–442.[Abstract/Free Full Text]

18. Jin L, Ying Z, Webb RC. Activation of RhoA/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol. 2004; 287: H1495–H1500.[Abstract/Free Full Text]

19. Geiman QM, Siddiqui WA, Schnell JV. Diabetes, a new mutation in the mouse. Science. 1966; 153: 1127–1130.[Abstract/Free Full Text]

20. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res. 2002; 91: 938–944.[Abstract/Free Full Text]

21. Didion SP, Faraci FM. Effect of NADH and NADPH on superoxide levels and cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2002; 282: H688–H695.[Abstract/Free Full Text]

22. Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM. Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol. 2002; 283: H1569–H1576.[Abstract/Free Full Text]

23. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997; 389: 990–994.[CrossRef][Medline] [Order article via Infotrieve]

24. Mayhan WG, Didion SP. Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension. Brain Res. 1995; 696: 106–112.[CrossRef][Medline] [Order article via Infotrieve]

25. Mayhan WG. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res. 1992; 580: 297–302.[CrossRef][Medline] [Order article via Infotrieve]

26. Mayhan WG, Simmons LK, Sharpe GM. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol. 1991; 260: H319–H326.[Medline] [Order article via Infotrieve]

27. Didion SP, Faraci FM. Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles. Stroke. 2003; 34: 2038–2042.[Abstract/Free Full Text]

28. Didion SP, Hathaway CA, Faraci FM. Superoxide levels and function of cerebral blood vessels after inhibition of CuZnSOD. Am J Physiol Heart Circ Physiol. 2001; 281: H1697–H1703.[Abstract/Free Full Text]

29. Fang Q, Sun H, Mayhan WG. Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol. 2003; 284: H528–H534.[Abstract/Free Full Text]

30. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 1999; 2: 157–161.[CrossRef][Medline] [Order article via Infotrieve]

31. Erdos B, Snipes JA, Miller AW, Busija DW. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes. 2004; 53: 1352–1359.[Abstract/Free Full Text]

32. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989; 159: 548–553.[CrossRef][Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				J. A. Lang, J. D. Jennings, L. A. Holowatz, and W. L. Kenney Reflex vasoconstriction in aged human skin increasingly relies on Rho kinase-dependent mechanisms during whole body cooling Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1792 - H1797. [Abstract] [Full Text] [PDF]

				R. D. Rudic and D. J. Fulton Pressed for time: the circadian clock and hypertension J Appl Physiol, October 1, 2009; 107(4): 1328 - 1338. [Abstract] [Full Text] [PDF]

				D. W. Nuno, J. S. Harrod, and K. G. Lamping Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1469 - H1477. [Abstract] [Full Text] [PDF]

				N. Toda, K. Ayajiki, and T. Okamura Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97. [Abstract] [Full Text] [PDF]

				A. K. Harris, M. M. Elgebaly, W. Li, K. Sachidanandam, and A. Ergul Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1213 - R1219. [Abstract] [Full Text] [PDF]

				A. M. Beyer, G. L. Baumbach, C. M. Halabi, M. L. Modrick, C. M. Lynch, T. D. Gerhold, S. M. Ghoneim, W. J. de Lange, H. L. Keen, Y.-S. Tsai, et al. Interference With PPAR{gamma} Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling Hypertension, April 1, 2008; 51(4): 867 - 871. [Abstract] [Full Text] [PDF]

				H. Kinoshita, N. Matsuda, Y. Kimoto, S. Tohyama, K. Hama, K. Nakahata, and Y. Hatano Sevoflurane, but Not Propofol, Prevents Rho Kinase-Dependent Contraction Induced by Sphingosylphosphorylcholine in the Porcine Coronary Artery Anesth. Analg., August 1, 2007; 105(2): 325 - 329. [Abstract] [Full Text] [PDF]

				J. Kitayama, F. M. Faraci, S. R. Lentz, and D. D. Heistad Cerebral Vascular Dysfunction During Hypercholesterolemia Stroke, July 1, 2007; 38(7): 2136 - 2141. [Abstract] [Full Text] [PDF]

				S. P. Didion, C. M. Lynch, and F. M. Faraci Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1579 - H1583. [Abstract] [Full Text] [PDF]

				A. Drouin, N. Thorin-Trescases, E. Hamel, J. R. Falck, and E. Thorin Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries Cardiovasc Res, January 1, 2007; 73(1): 73 - 81. [Abstract] [Full Text] [PDF]

				S. Chrissobolis and C. G. Sobey Recent Evidence for an Involvement of Rho-Kinase in Cerebral Vascular Disease Stroke, August 1, 2006; 37(8): 2174 - 2180. [Abstract] [Full Text] [PDF]

				G. L. Baumbach, S. P. Didion, and F. M. Faraci Hypertrophy of Cerebral Arterioles in Mice Deficient in Expression of the Gene for CuZn Superoxide Dismutase Stroke, July 1, 2006; 37(7): 1850 - 1855. [Abstract] [Full Text] [PDF]

				F. M. Faraci, M. L. Modrick, C. M. Lynch, L. A. Didion, P. E. Fegan, and S. P. Didion Selective cerebral vascular dysfunction in Mn-SOD-deficient mice J Appl Physiol, June 1, 2006; 100(6): 2089 - 2093. [Abstract] [Full Text] [PDF]

				K. Budzyn, M. Paull, P. D. Marley, and C. G. Sobey Segmental Differences in the Roles of Rho-Kinase and Protein Kinase C in Mediating Vasoconstriction J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 791 - 796. [Abstract] [Full Text] [PDF]

				F. M. Faraci Reactive oxygen species: influence on cerebral vascular tone J Appl Physiol, February 1, 2006; 100(2): 739 - 743. [Abstract] [Full Text] [PDF]

				Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF]

				J. S. Naik, L. Xiang, and R. L. Hester Enhanced role for RhoA-associated kinase in adrenergic-mediated vasoconstriction in gracilis arteries from obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R154 - R161. [Abstract] [Full Text] [PDF]

				F. M. Faraci Oxidative Stress: The Curse That Underlies Cerebral Vascular Dysfunction? Stroke, February 1, 2005; 36(2): 186 - 188. [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 36/2/342    most recent 01.STR.0000152952.42730.92v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Didion, S. P. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Didion, S. P. Articles by Faraci, F. M. Related Collections Animal models of human disease Type 2 diabetes Endothelium/vascular type/nitric oxide